Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Constantinos Zervas"'
Autor:
Dimitra Gika, A. Zomas, A A Meletios Dimopoulos, Donna M. Weber, Marie C. Kyrtsonis, Gerassimos A. Pangalis, Athanasios Anagnostopoulos, Constantinos Zervas, N. Anagnostopoulos, Raymond Alexanian
Publikováno v:
Leukemia & Lymphoma. 45:2057-2061
Recent data have suggested that rituximab is an active agent for the treatment of Waldenstrom's macroglobulinemia (WM). However, the patients that are more likely to benefit have not been clearly defined. In order to address this question we evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0b90dc69f11b59112107f78825ea55
https://doi.org/10.1080/10428190410001723287
https://doi.org/10.1080/10428190410001723287
Autor:
Panayiotis Panayiotidis, Nikolaos Anagnostopoulos, Meletios A. Dimopoulos, George Hamilos, Dimitra Gika, John Christakis, Constantinos Zervas, Eleni Efstathiou, Athanasios Zomas, Elina Vervessou
Publikováno v:
Clinical Lymphoma. 3:163-166
Waldenstrom's macroglobulinemia is a low-grade lymphoplasmacytoid lymphoma characterized by CD20 expression on malignant cells. Several studies have indicated that the anti-CD20 monoclonal antibody rituximab has activity against this disease. Thus, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a9c7dfdab88f6648627c58df4855ce1
https://doi.org/10.3816/clm.2002.n.022
https://doi.org/10.3816/clm.2002.n.022
Autor:
Christos Kiamouris, Christos Karkantaris, Nora Viniou, Chrisanthi Mitsouli, Constantinos Zervas, A. Zomas, Dimitra Gika, Vassiliki Grigoraki, John Christakis, Meletios A. Dimopoulos, Nikolaos Anagnostopoulos
Publikováno v:
Journal of Clinical Oncology. 20:2327-2333
PURPOSE: Waldenström’s macroglobulinemia (WM) is a low-grade lymphoplasmacytic lymphoma in which CD20 is usually expressed on tumor cells. There is evidence that patients with WM may benefit from treatment with the anti-CD20 monoclonal antibody ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b2813c2a1ff883d1d842d657cae0b13
https://doi.org/10.1200/jco.2002.09.039
https://doi.org/10.1200/jco.2002.09.039
Autor:
Athanasios Anagnostopoulos, Sosana Delimbasi, Constantinos Zervas, Panagiotis Repoussis, Anastasia Pouli, Meletios A. Dimopoulos, Friderikos Tsolakis, Evangelos Terpos, Argyris Symeonidis, T. Economopoulos
Publikováno v:
Leukemialymphoma. 47(8)
There are limited reports of young patients with multiple myeloma (MM) who presented with multiple lytic bone lesions but without intervening infiltration of bone marrow, a pattern consisting of macrofocal MM. In order to clearly define the clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d9d37d39a9a6bd2434923333c78fb22
https://pubmed.ncbi.nlm.nih.gov/16966252
https://pubmed.ncbi.nlm.nih.gov/16966252
Autor:
Gerrassimos Pangalis, N. Anagnostopoulos, Constantinos Bourantas, Athanasios Anagnostopoulos, Constantinos Zervas, Marie C Kyrtsonis, Meletios A. Dimopoulos, Athanasios Zomas
Publikováno v:
Scopus-Elsevier
Rituximab is an active agent for the treatment of Waldenstrom's macroglobulinemia. However, many patients do not respond to this agent and several others develop secondary resistance. In order to identify clinical and laboratory parameters that could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65845c1777cf880e393986933859992e
https://pubmed.ncbi.nlm.nih.gov/15794863
https://pubmed.ncbi.nlm.nih.gov/15794863
Autor:
Souzana Delimbasi, Constantinos Zervas, Panagiotis Repoussis, Fotis Tsolakis, Meletios A. Dimopoulos, Athanasios Angnostopoulos, Argyris Symeonidis, Anastasia Pouli
Publikováno v:
Blood. 106:3399-3399
Introduction: Most patients with multiple myeloma (MM) present with multiple lytic bone lesions, extensive marrow plasmacytosis and anemia. Furthermore in several of them hypercalcemia and renal impairment are evident at diagnosis. Over the years, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dace2620542a39d8482b01358b3d4743
https://doi.org/10.1182/blood.v106.11.3399.3399
https://doi.org/10.1182/blood.v106.11.3399.3399